查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
移动式心电遥测系统市场规模、份额及成长分析（按产品、疾病及地区划分）－产业预测（2026-2033年）
市场调查报告书
商品编码
1898219

移动式心电遥测系统市场规模、份额及成长分析（按产品、疾病及地区划分）－产业预测（2026-2033年）

Mobile Cardiac Telemetry Systems Market Size, Share, and Growth Analysis, By Product (Multiple Lead, Mobile Cardiac Telemetry Patch), By Disease Indication (Cardiovascular Diseases, Angina Pectoris), By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年，行动心电遥测系统市场规模将达到 10.4301 亿美元，到 2025 年将达到 11.6922 亿美元，到 2033 年将达到 29.1568 亿美元，在预测期（2026-2033 年将达到 29.1568 亿美元，在预测期（2026-2033 年）内复合年增长率为 12.1%。

行动心电遥测（MCAT）是一种先进的即时心臟监测技术，可为心臟病患者提供高效可靠的监测。这些先进的设备无需患者参与，即可自主采集心电图（ECG）数据并将其传输至远距离诊断机构，实现长期监测。与多种心血管疾病相关的死亡率不断上升是推动MCAT市场成长的主要因素。久坐不动的生活方式、肥胖和吸烟等生活方式因素正在增加这些疾病的发病率。此外，MCAT技术在检测接受门诊治疗的COVID-19患者的心律不整风险方面也发挥着重要作用。技术进步、设备研发投入的增加以及为减少患者就诊次数而转向远端患者监护的趋势，共同推动了对MCAT系统的需求。

移动式心电遥测系统市场驱动因素

微创手术技术在心臟护理领域的日益普及，显着推动了对移动心电遥测系统的需求。这些先进的系统能够即时监测病患的心臟活动，帮助医护人员在手术中和术后更精准地评估病患的病情。这种先进的心臟健康追踪能力有助于改善患者的整体预后，因为即时数据存取能够实现及时的决策和个人化的治疗方案。因此，将行动遥测技术应用于心臟护理，符合不断发展的医疗实践标准，旨在实现最佳復健和患者满意度。

行动心电遥测系统市场的限制因素

部署和运作行动心电遥测系统的成本可能是一个重大障碍，尤其对于中小型医疗机构而言。购置设备、对员工进行适当培训、维护技术等成本都构成阻碍，限制这些系统的广泛应用。在资源有限的医疗机构中，这种经济负担尤其沉重，导致许多机构难以有效地将这些先进的监测解决方案融入日常营运中。因此，在某些情况下，移动心电遥测系统的整体应用可能会受到限制。

移动式心电遥测系统市场趋势

行动心电遥测系统市场呈现强劲成长势头，这主要得益于医疗保健产业对远端患者监护解决方案日益增长的需求。患者越来越倾向于在家中即时追踪自身的心臟健康状况。这些系统有助于医疗服务提供者进行持续的数据分析，从而保障病人安全并改善治疗效果。这一市场趋势反映了远端医疗和数位化医疗解决方案的广泛应用，这些解决方案在提高便利性和效率的同时，最大限度地降低了面对面就诊的风险。此外，科技的进步以及对预防性健康管理日益重视，也进一步推动了这些创新的监护系统的应用。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析和影响

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术进步
  • 监管环境
  • 专利分析
  • 案例研究

全球行动心电遥测系统市场规模（按产品和复合年增长率划分）（2026-2033 年）

  • 多导联移动式心电遥测系统
  • 移动式心电遥测贴片

全球行动心电遥测系统市场规模（按疾病和复合年增长率划分）（2026-2033 年）

  • 心血管疾病
  • 心绞痛
  • 动脉粥状硬化
  • 心臟衰竭
  • 其他的

全球行动心电遥测系统市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

  • 医院
  • 心臟中心
  • 居家医疗环境
  • 其他的

全球行动心电遥测系统市场规模（按地区划分）及复合年增长率（2026-2033 年）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2021-2023年营收年比比较

主要企业简介

  • BioTelemetry, Inc.
  • ScottCare
  • Biotricity Inc.
  • Welch Allyn
  • Applied Cardiac Systems Inc.
  • Medicomp Inc.
  • Preventice Solutions
  • Telerhythmics LLC
  • Zoll Medical Corporation
  • iRhythm Technologies, Inc.

结论与建议

简介目录
Product Code: SQMIG35A2661

Mobile Cardiac Telemetry Systems Market size was valued at USD 1043.01 Million in 2024 and is poised to grow from USD 1169.22 Million in 2025 to USD 2915.68 Million by 2033, growing at a CAGR of 12.1% during the forecast period (2026-2033).

Mobile cardiac telemetry (MCAT) represents a cutting-edge approach to real-time cardiac monitoring, providing efficient and dependable oversight for patients with heart conditions. These sophisticated devices autonomously capture and transmit ECG data to remote diagnostics facilities without patient involvement, allowing for extended monitoring periods. Rising mortality linked to widespread cardiovascular issues is a key factor driving the MCAT market's growth. Contributing lifestyle factors, such as sedentary behavior, obesity, and smoking, have escalated the incidence of these conditions. Additionally, MCAT technology has found a crucial application in detecting arrhythmogenic risks in COVID-19 patients during outpatient care. Coupled with technological advancements, increased investment in device development, and a shift towards remote patient monitoring to curtail hospital visits, these factors collectively enhance the demand for MCAT systems.

Top-down and bottom-up approaches were used to estimate and validate the size of the Mobile Cardiac Telemetry Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Mobile Cardiac Telemetry Systems Market Segments Analysis

Global Mobile Cardiac Telemetry Systems Market is segmented by Product, Disease Indication, End-User, and region. Based on Product, the market is segmented into Multiple Lead Mobile Cardiac Telementry Systems, and Mobile Cardiac Telemetry Patch. Based on Disease Indication, the market is segmented into Cardiovascular Diseases, Angina Pectoris, Atherosclerosis, Heart Failure, and Other. Based on End-User, the market is segmented into Hospitals, Cardiac centres, Home Care Settings, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Mobile Cardiac Telemetry Systems Market

The rising popularity of minimally invasive surgical techniques in cardiac care is significantly fueling the demand for mobile cardiac telemetry systems. These advanced systems facilitate real-time monitoring of patients' cardiac activities, allowing healthcare professionals to evaluate patient status with greater precision during and after surgical interventions. This enhanced ability to track cardiac health contributes to better overall patient outcomes, as immediate data access helps in timely decision-making and tailored treatment approaches. Consequently, the integration of mobile telemetry technology into cardiac care aligns with the evolving standards of medical practices focused on achieving optimal recovery and patient satisfaction.

Restraints in the Mobile Cardiac Telemetry Systems Market

The expense of acquiring and implementing mobile cardiac telemetry systems can be a significant obstacle for healthcare facilities, especially for smaller and mid-sized providers. The costs related to purchasing equipment, ensuring proper training for staff, and maintaining the technology create barriers that impede broader acceptance of these systems. This financial burden can be particularly challenging in healthcare environments where resources are limited, making it difficult for many facilities to integrate these advanced monitoring solutions into their operations effectively. As a result, the overall adoption of mobile cardiac telemetry systems may be constrained in certain settings.

Market Trends of the Mobile Cardiac Telemetry Systems Market

The mobile cardiac telemetry systems market is experiencing robust growth, driven by the rising demand for remote patient monitoring solutions in healthcare. Patients increasingly favor real-time tracking of their cardiac health from home, as these systems facilitate continuous data analysis by healthcare providers, enhancing patient safety and outcomes. This market trend reflects a broader shift towards telehealth and digital healthcare solutions, allowing for greater convenience and efficiency while minimizing the risks associated with in-person visits. Moreover, advancements in technology and a growing emphasis on proactive health management further bolster the adoption of these innovative monitoring systems.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Mobile Cardiac Telemetry Systems Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Multiple Lead Mobile Cardiac Telemetry Systems
  • Mobile Cardiac Telemetry Patch

Global Mobile Cardiac Telemetry Systems Market Size by Disease Indication & CAGR (2026-2033)

  • Market Overview
  • Cardiovascular Diseases
  • Angina Pectoris
  • Atherosclerosis
  • Heart Failure
  • Other

Global Mobile Cardiac Telemetry Systems Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Cardiac centres
  • Home Care Settings
  • Others

Global Mobile Cardiac Telemetry Systems Market Size & CAGR (2026-2033)

  • North America (Product, Disease Indication, End-User)
    • US
    • Canada
  • Europe (Product, Disease Indication, End-User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product, Disease Indication, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product, Disease Indication, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Disease Indication, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • BioTelemetry, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScottCare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotricity Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Welch Allyn
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Applied Cardiac Systems Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicomp Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Preventice Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Telerhythmics LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoll Medical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation